- Home
- Equipment
- switzerland
- clinical feasibility study
Show results for
Refine by
Clinical Feasibility Study Equipment Supplied In Switzerland
28 equipment items found
Manufactured by:ReproNovo based inLausanne, SWITZERLAND
With our lead product candidate, RPN-001 (leflutrozole), the focus of our clinical research is on treating infertile men with low serum testosterone. RPN-001 is a novel molecular entity with the potential to enhance spermatogenesis. By inhibiting the aromatase enzyme, leflutrozole suppresses the conversion of testosterone to estradiol, thereby normalizing testosterone levels and rebalancing the ...
Manufactured by:Precision For Medicine, Inc. based inFrederick, MARYLAND (USA)
Clinical and research-grade leukopaks - mobilized or non-mobilized from healthy and diseased subjects, including oncology donors. ...
Manufactured by:Activen SA based inLausanne, SWITZERLAND
XEP®-018 is a muscle relaxant miniprotein™ naturally present in the venom of the sea snail Conus consors that lives in the Pacific Ocean. This predatory snail uses this miniprotein™ to immobilize its prey rapidly & efficiently. The key role of muscle relaxants in the treatment and prevention of wrinkles has been established by decades of experience in botulinum toxin ...
Manufactured by:Alnylam Pharmaceuticals, Inc. based inCambridge, MASSACHUSETTS (USA)
AMVUTTRA™ (vutrisiran) is a prescription medicine given once every 3 months by a healthcare professional to treat the polyneuropathy caused by an illness called hereditary ATTR (hATTR) amyloidosis in adults. In an 18-month clinical study, AMVUTTRA-treated patients showed significant improvement in nerve function and quality of life at 9 months and continued to improve throughout the ...
Manufactured by:ReproNovo based inLausanne, SWITZERLAND
Our second asset RPN-002 (nolasiban) is an oxytocin receptor antagonist. RPN-002 has the potential to increase pregnancy rates and live birth rates in women undergoing embryo transfer after IVF. Clinical studies have demonstrated that blocking oxytocin receptor activation can decrease uterine contractions, increase blood flow to the lining of the uterus and help it better prepare for pregnancy by ...
by:Timeline® a company by Amazentis SA based inLausanne, SWITZERLAND
Mitopure® is a highly pure form of Urolithin A, a postbiotic clinically shown to energize cells, increase muscle strength and improve endurance. And this is just the beginning. New studies continuously explore and prove the incredible potential of Urolithin A. ...
Manufactured by:CELONIC Group based inBasel, SWITZERLAND
Our human GEX® platform is the best choice when working with defucosylated antibodies, complex molecules or glycosylated proteins. GEX® technology allows the optimization of glycosylation to improve critical quality attributes for better clinical performance, such as potency, bioavailability, stability and/or immunogenicity. This technology is based on a human cell line family optimized ...
Manufactured by:EMS Company based inNyon, SWITZERLAND
20 W versatile Holmium:YAG laser, optimum energy and pulse ...
Manufactured by:Kuros Biosciences A.G. based inSchlieren, SWITZERLAND
MagnetOs isn’t like other bone grafts. It grows bone even in soft tissue thanks to our unique NeedleGrip™ surface technology which provides traction for our body’s vitally important ‘pro-healing’ immune cells (M2 macrophages).*†6,7 This in turn, unlocks previously untapped potential to stimulate stem cells – and form new bone throughout the graft.*8-10 ...
Manufactured by:Nobel Biocare based inKloten, SWITZERLAND
A membrane with outstanding handling1,2 that facilitates bone gain. A resorbable collagen membrane for guided bone regeneration and guided tissue regeneration ...
Manufactured by:Sequana Medical NV based inSint-Denijs Westrem, BELGIUM
Direct Sodium Removal (DSR®) therapy is Sequana Medical’s novel and proprietary approach under development for the management of fluid overload due to heart failure. The sodium concentration in patients with fluid overload is in balance but there is too much sodium and too much fluid in the body. Sequana Medical’s approach is to remove excess sodium in patients with ...
Manufactured by:Auris Medical AG based inBasel, SWITZERLAND
The OligoPhore™ / SemaPhore™ technology has been extensively and successfully tested with various siRNA and mRNA sequences in numerous disease models in mice. For the development of our first proprietary drug product, AM-401 (OligoPhore™ siRNA targeting KRAS), we have initiated a program of IND-enabling ...
Manufactured by:Medacta International based inCastel San Pietro, SWITZERLAND
AMIStem-P is the evolution of a successful and proven femoral stem concept, originally born to simplify the AMIS approach without compromising implant ...
Manufactured by:Regen Lab SA based inVaud, SWITZERLAND
Cellular Matrix® tubes allow the preparation of autologous platelet-rich plasma (RegenPRP®) combined with a non-crosslinked hyaluronic acid (HA) in a closed-circuit system. CM-PRP-HA has an excellent safety profile in clinical practice.1,3,4. Cellular Matrix® technology combines the complementary clinical effects of RegenPRP® and hyaluronic acid (HA), giving better and ...
Manufactured by:Sequana Medical NV based inSint-Denijs Westrem, BELGIUM
The alfapump® system is a fully implantable pump system that collects ascites as it forms and moves it into the bladder, where it is passed naturally from the body through urination. The implantation procedure can be performed under local or general anaesthesia in less than one hour. Once implanted, patient interaction with the alfapump® system is minimal. The patient simply charges the ...
Manufactured by:Regen Lab SA based inVaud, SWITZERLAND
Cellular Matrix tubes allow the preparation of autologous platelet-rich plasma (RegenPRP) combined with a non-crosslinked hyaluronic acid (HA) in a closed-circuit system. CM-PRP-HA has an excellent safety profile in clinical practice.1,3,4 Cellular Matrix technology combines the complementary clinical effects of RegenPRP and hyaluronic acid (HA), giving better and longer-lasting results in ...
by:STALICLA based inGeneve, SWITZERLAND
STALICLA’s precision medicine approach begins with ‘endophenotyping’-identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures. DEPI matches these patient subgroups with an NDD-targeted drug (or drug combination) by integrating and analyzing large omics data sets, including genomics, ...
Manufactured by:Regen Lab SA based inVaud, SWITZERLAND
The RegenKit® BCT are medical devices intended for the preparation of RegenPRP. They contain RegenBCT® tubes and accessories for blood collection and PRP recovery. RegenBCT® tubes are made of pharmaceutical grade glass with a vacuum for automated blood collection. They contain a sodium citrate anticoagulant solution and a separating gel to separate plasma and platelets from the blood ...
Manufactured by:Glaukos Corporation based inSan Clemente, CALIFORNIA (USA)
iStent inject® W is indicated for use in conjunction with cataract surgery for the reduction of IOP in adult patients with mild to moderate primary open-angle ...
Manufactured by:Medacta International based inCastel San Pietro, SWITZERLAND
MOTO Lateral is a compartment-specific, fixed-bearing implant that further expands the MOTO Partial Knee System, offering the opportunity to treat osteoarthritis localized on the lateral femoral and tibial condyles. MOTO Lateral and MOTO Medial provide the surgeon with a comprehensive range of options to resurface only the affected portion of the patient’s ...